gene in sufferers relapsing following therapy Using the BCL2 antagonist venetoclax. sixty six Resistance to these agents is affiliated with these mutations in close to 70% of circumstances, Even though they are generally subclonal and their distinct purpose producing resistance really should be established.??? "?????????????????????????????????????